Free shipping on all orders over $ 500

Anastrozole

Cat. No. M3708

All AbMole products are for research use only, cannot be used for human consumption.

Anastrozole Structure
Synonym:

Arimidex, ZD1033

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mg USD 30 In stock
50mg USD 84 In stock
100mg USD 130 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Anastrozole can be replaced by letrozole any time during endocrine therapy. The patients taking anastrozole plus letrozole surprisingly seemed to have better OS than patients taking anastrozole alone. Exemestane and anastrozole appear to offer benefit for postmenopausal woman at high risk for invasive breast cancer and are well tolerated. When present first-year data from a direct comparison of anastrozole and letrozole for height augmentation in short pubertal boys. Letrozole was more potent in hormonal manipulation than anastrozole. First-year growth velocities were comparable, but improvement in PAH was greater in the anastrozole group.

Chemical Information
Molecular Weight 293.37
Formula C17H19N5
CAS Number 120511-73-1
Solubility (25°C) DMSO 34 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Aphinives P, et al. Breast Cancer (Dove Med Press). Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy.

[2] Ingle JN, et al. Steroids. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.

[3] Olin JL, et al. Ann Pharmacother. Aromatase Inhibitors in Breast Cancer Prevention.

[4] Neely EK, et al. J Clin Endocrinol Metab. Letrozole vs Anastrozole for Height Augmentation in Short Pubertal Males: First Year Data.

Related Cytochrome P450 (e.g. CYP17) Products
Abiraterone

Abiraterone acetate (CB-7598) is a potent, selective, and orally available inhibitor of CYP17 with an IC50 of 4 nM.

Avasimibe

Avasimibe (CI-1011) is a novel orally bioavailable ACAT inhibitor with IC50 values of 2.9, 13.9, 26.5 µM for CYP2C9, CYP1A2 and CYP2C19, respectively.

Imidaclopride

Imidaclopride is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids.

Ketoconazole

Ketoconazole (R-41400) is an imidazole anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor.

Chrysin

Chrysin is a naturally occurring flavone chemically extracted from the passion flowers Passiflora caerulea.

  Catalog
Abmole Inhibitor Catalog




Keywords: Anastrozole, Arimidex, ZD1033 supplier, Cytochrome P450 (e.g. CYP17), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.